NeuroSense Therapeutics Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
NeuroSense Therapeutics Ltd. (NRSN) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.38% for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-03-31
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|
| 2025-12-31 | 4.38% 20-F · filed 2026-03-31 |
| 2024-06-26 | 4.40% 6-K · filed 2024-09-30 |
| 2023-12-31 | 3.64% 20-F · filed 2026-03-31 |